BiomX Inc. (PHGE): Submission of Matters to a Vote of Security Holders
BiomX Inc. (PHGE) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0001739174 0001739174 2026-06-26 2026-06-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Repor
How this was made
The 30-second read
Why it matters
Key items: (1) election of Ran Shaked as sole Class III director nominee; (2) approval of an amendment to the 2026 Equity Incentive Plan increasing reserved shares from 1.39M to 6.85M; (3) adjournment proposal approved but ultimately not needed.
Market read
The only actionable company-specific change is shareholder approval to expand the equity incentive plan share pool, which can affect future dilution expectations.
What to watch
Traders may be over-weighting dilution risk; the filing provides no information on timing/size of future option grants or whether the company plans to issue shares soon.
Background
The SEC 8-K (Item 5.07) reports final certified results from BiomX’s June 26, 2026 virtual annual meeting.
Ticker impact
BiomX reported 2026 annual meeting vote results, including director election and approval of an equity plan share increase to 6.85M.
Likely limited near-term impact; any effect would be through expectations for future equity issuance/dilution rather than immediate fundamentals.
The filing is a routine 8-K tabulating votes; the only company-specific decision is the equity plan share increase, which is typically incremental unless paired with a near-term financing or guidance change (not present here).
Market effects
Minimal sector read-through; this is company-specific governance/equity-plan mechanics.
No clear regional spillover indicated by the filing.
No global macro or cross-border transaction disclosed.
Counterpoint
The equity plan approval may be largely administrative; without details on actual grants or a financing, it may not change trading behavior meaningfully.
Key entities
- companyBiomX Inc.
Subject of the SEC 8-K; reported annual meeting vote outcomes including equity plan share increase.
- personRan Shaked
Elected sole Class III director nominee to serve until the 2029 annual meeting.
